Inviragen Presents Safety and Immune Response Data from a P1 Study of its Two-Dose Dengue Vaccine
- 7 December 2012
Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.
© 2021- edbi. All rights reserved.